Judge Potentially Limits Claims in Avandia MDL

Law360, New York (August 9, 2012, 3:06 PM EDT) -- A Pennsylvania federal judge on Tuesday set a deadline date for heart disease claims against GlaxoSmithKline PLC over diabetes drug Avandia, which could retroactively reduce the number of claims in a broader multidistrict litigation against the pharmaceutical giant.

The ruling will affect only claims that use of the drug led to heart disease. In dismissing claims by Marvin Rainey and Amjad Faheem that the drug caused their heart attacks, U.S. District Judge Cynthia Rufe said a series of events in 2007 publicizing the connection between Avandia...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.